What if you could sequence your hybridoma antibodies at the industry's lowest cost, with faster turnaround and greater confidence than your current provider?
 
Unbeatable Price. Made in USA. Near-100% Success.
This is how we are helping labs worldwide rethink hybridoma sequencing.
 
In a recent oncology study, a client needed full antibody characterization without prior isotype information. Within just 10 business days, we delivered:
 • Verified variable regions (~500 bp) and constant regions (~400–600 bp)
 • >95% sequence integrity
 • ≥4 productive sequences per clone
 • Data ready for recombinant expression with no rework required
 
Compared to conventional sequencing providers, our clients consistently achieve lower costs, faster turnaround times, and higher success rates, even for difficult samples.
 
Synbio Tech makes this possible through comprehensive isotype screening, optimized primer design, and high-quality RNA-to-cDNA workflows, all performed in the U.S. for reliable, consistent results.

 
If you’ve dealt with failed sequencing, unclear data, or high costs, there’s a better way.
Send us your toughest sequence. Let’s prove it.
 
 
Synbio Technologies LinkedIn X Facebook Facebook

Thank you for connecting with us! Click "Subscribe" to receive valuable insights and news. If you prefer not to receive further emails, just hit "Unsubscribe" — your choice is always respected.
Synbio Technologies LLC
9 Deer Prk Dr., Suite J-25, Monmouth Junction, NJ 08852, USA